12 Health Care Stocks Moving In Thursday’s Intraday Session

Gainers Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday’s regular session. The market value of…

Gainers

  • Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday’s regular session. The market value of their outstanding shares is at $3.4 million.
  • Processa Pharma (NASDAQ:PCSA) stock moved upwards by 43.18% to $2.32. The market value of their outstanding shares is at $6.6 million.
  • Akso Health Group (NASDAQ:AHG) shares moved upwards by 29.87% to $1.0. The market value of their outstanding shares is at $109.5 million.
  • Eyenovia (NASDAQ:EYEN) shares increased by 22.87% to $0.72. The company’s market cap stands at $33.9 million.
  • Predictive Oncology (NASDAQ:POAI) stock increased by 21.64% to $1.63. The company’s market cap stands at $6.6 million.
  • IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 18.93% to $4.14. The market value of their outstanding shares is at $4.7 million.

Losers

  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock declined by 33.1% to $1.54 during Thursday’s regular session. The market value of their outstanding shares is at $2.0 million.
  • Organogenesis Hldgs (NASDAQ:ORGO) stock decreased by 22.32% to $2.31. The market value of their outstanding shares is at $305.4 million.
  • Xylo Technologies (NASDAQ:XYLO) shares decreased by 16.35% to $1.74. The market value of their outstanding shares is at $3.2 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 14.31% to $1.4. The market value of their outstanding shares is at $6.2 million.
  • American Oncology Network (NASDAQ:AONC) shares fell 14.14% to $3.95. The company’s market cap stands at $41.8 million.
  • INVO Bioscience (NASDAQ:INVO) shares decreased by 13.68% to $1.01. The market value of their outstanding shares is at $2.7 million.
    See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cleveland-Cliffs, Nucor Shares Are Sliding Tuesday: What’s Going On?

After the market close on Monday, Cleveland-Cliffs reported first-quarter revenue of $5.2 billion, which missed the consensus estimate of $5.346 billion, according to Benzinga Pro. The company reported adjusted earnings of 18 cents per share, which missed analyst estimates of 22 cents per share. Steel shipments came in at 3.9 million net tons in the first quarter.

CLF